Better Context → Better Decisions
Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers with corporate access will find a wealth of contextualized life science insight ready to be viewed in the FENIX Marketplace.
Welcome to FENIX Syndicated Services. If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact us.
$599
Posted in: Basal Insulin, Bolus Insulin, Dual/triple agonist, GLP-1RA, GLP-1RA + Basal, Other Aug 07 | 2020Novo Q2 '20 Roadshow; Provention Bio Q2 '20 Earnings Update; Senseonics Eversense Covered by HighmarkPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, Insulin Delivery Aug 06 | 2020Mylan Filed for Glargine Interchangeability; Insulet, Mylan, and BD Q2 '20 Earnings UpdatesPurchase Blast$599
Posted in: Basal Insulin, Bolus Insulin, GLP-1RA, GLP-1RA + Basal, Other Aug 06 | 2020Novo Discontinues its Dual/Triple Agonists for Obesity; Novo Q2 '20 Earnings UpdatePurchase Blast
$599
Posted in: Bolus Insulin Aug 05 | 2020David Kendall to Leave MannKind; MannKind Q2 '20 Earnings UpdatePurchase Blast
$599
Posted in: Glucose Monitoring, Insulin Delivery, Other, SGLT2i Aug 05 | 2020Livongo to Merge with Teladoc; AZ Partners for HF Diagnostic; ViaCyte Partners with Gore for Novel Membrane Development; Teva Q2 '20 Earnings UpdatePurchase Blast
$599
Posted in: Dual/triple agonist, Other, SGLT2i Aug 04 | 2020Merck In-licenses Hanmi's Dual Agonist for NASH; Generic Empagliflozin Tentative ApprovalPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin Aug 03 | 2020Lilly Initiates New Connected Pen TrialPurchase Blast
$599
Posted in: Autologous, BCMA, CAR-T Jul 30 | 2020BMS and bluebird bio Resubmit Ide-cel to FDA; Dynamic H1 2021 BCMA Launch Environment Expected with JanssenPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, DPP-IVi, GLP-1RA, Glucagon, Insulin Delivery, SGLT2i Jul 30 | 2020EMPEROR-Reduced Positive Topline Results; AZ Discontinues its GLP-1RA Small Molecule; Lexicon to Reorganize; Lilly, AZ, and Lexicon Q2 '20 Earnings UpdatesPurchase Blast
$599
Posted in: Autologous, CAR-T, CD19 Jul 30 | 2020Thoughts on the EMA Validating BMS's Liso-cel Marketing Authorization ApplicationPurchase Blast
$599
Posted in: Glucose Monitoring Jul 29 | 2020Libre 2 Launched in the US; Libre 2 App Not Yet AvailablePurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, GLP-1RA + Basal Jul 29 | 2020Sanofi Q2 '20 Earnings UpdatePurchase Blast
$599
Posted in: GLP-1RA, Glucose Monitoring, SGLT2i Jul 28 | 2020Dexcom and Pfizer Q2 '20 Earnings UpdatesPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin Jul 24 | 2020Biocon Levels-up Insulin Strategy - Biocon CY Q2 '20 Earnings UpdatePurchase Blast
$599
Posted in: Glucose Monitoring, Insulin Delivery Jul 23 | 2020Dexcom Partners with Current Health for Remote Patient Monitoring; Nemaura to Integrate with Activity Trackers; Roche Q2 '20 Earnings UpdatePurchase Blast
$599
Posted in: Glucose Monitoring Jul 23 | 2020New Non-Invasive CGM Player Emerges (Movano); Dexcom G6 Direct-to-Apple Watch Delayed?Purchase Blast